ACORN BIOVENTURES, L.P. - 01 Dec 2025 SCHEDULE 13G Report for Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value (JSPR)

Filing Manager
ACORN BIOVENTURES, L.P.
Reporting Manager
Anders Hove
Security
Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value
Symbol
JSPR
Shares outstanding
27,913,938 shares
Disclosed Ownership
1,786,492 shares
Ownership
6.4%
Form type
SCHEDULE 13G
Filing time
02 Dec 2025, 10:23:49 UTC
Date of event
01 Dec 2025
Next filing
26 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ACORN BIOVENTURES, L.P. disclosed 6.4% ownership in Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value (JSPR) on 01 Dec 2025."

Quick Takeaways

  • ACORN BIOVENTURES, L.P. filed SCHEDULE 13G for Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value (JSPR).
  • Disclosed ownership: 6.4%.
  • Date of event: 01 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 02 Dec 2025, 10:23.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ACORN BIOVENTURES, L.P. 2.7% 750,326 0 750,326 Anders Hove Manager of General Partner
ACORN CAPITAL ADVISORS GP, LLC 2.7% 750,326 0 750,326 Anders Hove Manager
ACORN BIOVENTURES 2, L.P. 3.7% 1,036,166 0 1,036,166 Anders Hove Manager of General Partner
Acorn Capital Advisors GP 2, LLC 3.7% 1,036,166 0 1,036,166 Anders Hove Manager
Anders Hove 6.4% 1,786,492 0 1,786,492 Anders Hove Individually

Sponsored